Voya Investment Management LLC Sells 3,104 Shares of Davita Inc (DVA)
Voya Investment Management LLC cut its stake in shares of Davita Inc (NYSE:DVA) by 4.2% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 71,386 shares of the company’s stock after selling 3,104 shares during the period. Voya Investment Management LLC’s holdings in Davita were worth $4,957,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds also recently modified their holdings of the company. Vigilant Capital Management LLC raised its position in Davita by 250.0% during the second quarter. Vigilant Capital Management LLC now owns 2,100 shares of the company’s stock valued at $146,000 after purchasing an additional 1,500 shares during the period. BNP PARIBAS ASSET MANAGEMENT Holding S.A. purchased a new stake in Davita during the second quarter valued at approximately $206,000. IBM Retirement Fund purchased a new stake in Davita during the first quarter valued at approximately $212,000. IFG Advisory LLC purchased a new stake in Davita during the second quarter valued at approximately $213,000. Finally, Jane Street Group LLC purchased a new stake in Davita during the first quarter valued at approximately $243,000. Institutional investors and hedge funds own 87.71% of the company’s stock.
Shares of NYSE DVA opened at $70.13 on Thursday. The company has a current ratio of 1.90, a quick ratio of 1.88 and a debt-to-equity ratio of 1.82. Davita Inc has a fifty-two week low of $52.51 and a fifty-two week high of $80.71. The company has a market capitalization of $11.67 billion, a PE ratio of 18.26, a price-to-earnings-growth ratio of 1.04 and a beta of 1.10.
DVA has been the topic of a number of recent research reports. Zacks Investment Research downgraded Davita from a “buy” rating to a “hold” rating in a research report on Wednesday, August 1st. JPMorgan Chase & Co. upgraded Davita from an “underweight” rating to a “neutral” rating in a research report on Thursday, September 13th. Finally, William Blair restated a “buy” rating on shares of Davita in a research report on Wednesday, June 6th. Five investment analysts have rated the stock with a hold rating, five have given a buy rating and one has given a strong buy rating to the company’s stock. Davita presently has an average rating of “Buy” and a consensus target price of $82.13.
Davita Company Profile
DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease (ESRD). The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.
Featured Story: Do closed-end mutual funds pay dividends?
Want to see what other hedge funds are holding DVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Davita Inc (NYSE:DVA).
Receive News & Ratings for Davita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Davita and related companies with MarketBeat.com's FREE daily email newsletter.